You are now visiting tipharma.com.
On 1 January, 2016, TI Pharma and CTMM merged
to form a new organization called Lygature.
Please note that information on the tipharma.com site has not
been updated since, and is retained as an archive.
For up-to-date information, please visit lygature.org.
The name change follows the merger of the Center for Translational Molecular Medicine (CTMM) and...Read more
In a bid to stimulate the development of much needed treatments for osteoarthritis, a consortium of...Read more
Innovative medicines may be brought to patients faster. How this can be achieved is investigated by...Read more
Reference work discusses the challenges of developing NBCDs and their follow-on versions,...Read more
A report from the CTMM + TI Pharma Launch MeetingRead more
Utrecht, June 9, 2015 - Today, CTMM and TI Pharma, the two largest public-private top institutes in...Read more
The second research grant from GHIT provides further support for the Phase II development of a...Read more
June 9, 2015 Muntgebouw UtrechtRead more
The prestigious Bio-IT World Best Practices prize has been granted to the European Lead Factory...Read more
Dutch government invests in the pearls of previous research Eindhoven - April 23, 2015Read more